Nebula Research & Development LLC Acadia Pharmaceuticals Inc Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 50,037 shares of ACAD stock, worth $737,045. This represents 0.11% of its overall portfolio holdings.
Number of Shares
50,037
Previous 36,196
38.24%
Holding current value
$737,045
Previous $557 Million
64.93%
% of portfolio
0.11%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding ACAD
# of Institutions
327Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$632 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$205 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$178 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$128 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$107 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.38B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...